{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:52:26Z","timestamp":1780087946019,"version":"3.54.0"},"reference-count":322,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Cell. Neurosci."],"DOI":"10.3389\/fncel.2015.00055","type":"journal-article","created":{"date-parts":[[2015,2,26]],"date-time":"2015-02-26T15:16:53Z","timestamp":1424963813000},"source":"Crossref","is-referenced-by-count":19,"title":["Targeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromes"],"prefix":"10.3389","volume":"9","author":[{"given":"Hansen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandipan","family":"Pati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Pozzo-Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie C.","family":"Doering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2015,2,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"18208","DOI":"10.1073\/pnas.1012104107","article-title":"Correction of respiratory disorders in a mouse model of Rett syndrome","volume":"107","author":"Abdala","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1165\/rcmb.2013-0372OC","article-title":"Effect of Sarizotan, a 5-HT1a and D2-like receptor agonist, on respiration in three mouse models of Rett syndrome","volume":"50","author":"Abdala","year":"2014","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3389\/fncel.2014.00081","article-title":"CYFIP family proteins between autism and intellectual disability: links with Fragile X syndrome","volume":"8","author":"Abekhoukh","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/13810","article-title":"Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2","volume":"23","author":"Amir","year":"1999","journal-title":"Nat. Genet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/491196a","article-title":"Translational medicine: mice and men show the way","volume":"491","author":"Anagnostou","year":"2012","journal-title":"Nature"},{"key":"B6","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.brainres.2014.01.049","article-title":"Intranasal oxytocin in the treatment of autism spectrum disorders: a review of literature and early safety and efficacy data in youth","volume":"1580","author":"Anagnostou","year":"2014a","journal-title":"Brain Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1503\/cmaj.121756","article-title":"Autism spectrum disorder: advances in evidence-based practice","volume":"186","author":"Anagnostou","year":"2014b","journal-title":"CMAJ"},{"key":"B8","doi-asserted-by":"publisher","first-page":"4389","DOI":"10.1073\/pnas.0910249107","article-title":"Promoting social behavior with oxytocin in high-functioning autism spectrum disorders","volume":"107","author":"Andari","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nature10658","article-title":"Mutations causing syndromic autism define an axis of synaptic pathophysiology","volume":"480","author":"Auerbach","year":"2011","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.molmed.2014.03.004","article-title":"MeCP2: the long trip from a chromatin protein to neurological disorders","volume":"20","author":"Ausi\u00c3\u00b3","year":"2014","journal-title":"Trends Mol. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3389\/fncel.2014.00058","article-title":"Genetic aspects of autism spectrum disorders: insights from animal models","volume":"8","author":"Banerjee","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.neuron.2008.10.004","article-title":"Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function","volume":"60","author":"Bassell","year":"2008","journal-title":"Neuron"},{"key":"B13","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.tins.2004.04.009","article-title":"The mGluR theory of fragile X mental retardation","volume":"27","author":"Bear","year":"2004","journal-title":"Trends Neurosci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1177\/1073858412438697","article-title":"The GABA excitatory\/inhibitory shift in brain maturation and neurological disorders","volume":"18","author":"Ben-Ari","year":"2012","journal-title":"Neuroscientist"},{"key":"B15","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.pediatrneurol.2013.12.001","article-title":"Mechanism-based treatments in neurodevelopmental disorders: fragile X syndrome","volume":"50","author":"Berry-Kravis","year":"2014","journal-title":"Pediatr. Neurol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1097\/DBP.0b013e31829d1f20","article-title":"Outcome measures for clinical trials in fragile X syndrome","volume":"34","author":"Berry-Kravis","year":"2013","journal-title":"J. Dev. Behav. Pediatr."},{"key":"B17","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1136\/jmg.2008.063701","article-title":"A pilot open label, single dose trial of fenobam in adults with fragile X syndrome","volume":"46","author":"Berry-Kravis","year":"2009","journal-title":"J. Med. Genet."},{"key":"B18","doi-asserted-by":"publisher","first-page":"152ra127","DOI":"10.1126\/scitranslmed.3004214","article-title":"Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trial","volume":"4","author":"Berry-Kravis","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s11689-011-9074-7","article-title":"Targeted treatments for fragile X syndrome","volume":"3","author":"Berry-Kravis","year":"2011","journal-title":"J. Neurodev. Disord."},{"key":"B20","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1089\/cap.2006.16.525","article-title":"Effect of CX516, an AMPA-modulating compound, on cognition and behavior in fragile X syndrome: a controlled trial","volume":"16","author":"Berry-Kravis","year":"2006","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/DBP.0b013e31817dc447","article-title":"Open-label treatment trial of lithium to target the underlying defect in fragile X syndrome","volume":"29","author":"Berry-Kravis","year":"2008","journal-title":"J. Dev. Behav. Pediatr."},{"key":"B22","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1146\/annurev-neuro-060909-153138","article-title":"The pathophysiology of fragile, X (and what it teaches us about synapses)","volume":"35","author":"Bhakar","year":"2012","journal-title":"Annu. Rev. Neurosci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.neuron.2012.07.022","article-title":"Genetic removal of p70 S6 kinase 1 corrects molecular, synaptic and behavioral phenotypes in fragile X syndrome mice","volume":"76","author":"Bhattacharya","year":"2012","journal-title":"Neuron"},{"key":"B24","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrg1878","article-title":"Molecular genetics of Rett syndrome: when DNA methylation goes unrecognized","volume":"7","author":"Bienvenu","year":"2006","journal-title":"Nat. Rev. Genet."},{"key":"B25","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1136\/jmg.2008.061796","article-title":"Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model","volume":"46","author":"Bilousova","year":"2009","journal-title":"J. Med. Genet."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1002\/ar.21380","article-title":"Temporal and regional alterations in NMDA receptor expression in Mecp2-null mice","volume":"294","author":"Blue","year":"2011","journal-title":"Anat. Rec. (Hoboken)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/1531-8249(199904)45:4541::aid-ana213.0.co;2-2","article-title":"Development of amino acid receptors in frontal cortex from girls with Rett syndrome","volume":"45","author":"Blue","year":"1999","journal-title":"Ann. Neurol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1111\/ejn.12488","article-title":"Reversal of activity-mediated spine dynamics and learning impairment in a mouse model of Fragile X syndrome","volume":"39","author":"Boda","year":"2014","journal-title":"Eur. J. Neurosci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1172\/jci27607","article-title":"Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase","volume":"116","author":"Borrell-Pag\u00c3\u00a8s","year":"2006","journal-title":"J. Clin. Invest."},{"key":"B30","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/s0959-4388(99)80044-0","article-title":"Roles of metabotropic glutamate receptors in LTP and LTD in the hippocampus","volume":"9","author":"Bortolotto","year":"1999","journal-title":"Curr. Opin. Neurobiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.drudis.2014.01.013","article-title":"Fragile X syndrome neurobiology translates into rational therapy","volume":"19","author":"Braat","year":"2014","journal-title":"Drug Discov. Today"},{"key":"B32","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.tins.2006.06.007","article-title":"Synaptic plasticity: one STEP at a time","volume":"29","author":"Braithwaite","year":"2006","journal-title":"Trends Neurosci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00109-010-0704-4","article-title":"Readthrough of nonsense mutations in Rett syndrome: evaluation of novel aminoglycosides and generation of a new mouse model","volume":"89","author":"Brendel","year":"2011","journal-title":"J. Mol. Med. (Berl.)"},{"key":"B34","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/nn.2563","article-title":"Fragile X mental retardation protein controls gating of the sodium-activated potassium channel slack","volume":"13","author":"Brown","year":"2010","journal-title":"Nat. Neurosci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/bf02098506","article-title":"Reduced concentrations and increased metabolism of biogenic amines in a single case of Rett-syndrome: a postmortem brain study","volume":"68","author":"Br\u00c3\u00bccke","year":"1987","journal-title":"J. Neural Transm."},{"key":"B36","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.brainresbull.2013.11.005","article-title":"Rapamycin improves sociability in the BTBR T(+)Itpr3(tf)\/J mouse model of autism spectrum disorders","volume":"100","author":"Burket","year":"2014","journal-title":"Brain Res. Bull."},{"key":"B37","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nm.3127","article-title":"Targeting the endocannabinoid system in the treatment of fragile X syndrome","volume":"19","author":"Busquets-Garcia","year":"2013","journal-title":"Nat. Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1002\/ajmg.a.36750","article-title":"Effect of lovastatin on behavior in children and adults with fragile X syndrome: an open-label study","volume":"164A","author":"\u00c3\u2021aku","year":"2014","journal-title":"Am. J. Med. Genet. A"},{"key":"B39","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/hipo.22360","article-title":"Excitation\/inhibition imbalance and impaired synaptic inhibition in hippocampal area CA3 of Mecp2 knockout mice","volume":"25","author":"Calfa","year":"2015","journal-title":"Hippocampus"},{"key":"B40","doi-asserted-by":"publisher","first-page":"14074","DOI":"10.1523\/JNEUROSCI.3287-12.2012","article-title":"Treatment of neurodevelopmental disorders in adulthood","volume":"32","author":"Castr\u00c3\u00a9n","year":"2012","journal-title":"J. Neurosci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"9941","DOI":"10.1073\/pnas.1311685111","article-title":"Functional recovery with recombinant human IGF1 treatment in a mouse model of Rett syndrome","volume":"111","author":"Castro","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B42","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/WCO.0b013e32835f19a7","article-title":"Mechanisms and therapeutic challenges in autism spectrum disorders: insights from Rett syndrome","volume":"26","author":"Castro","year":"2013","journal-title":"Curr. Opin. Neurol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.nlm.2013.06.013","article-title":"Molecular and cellular mechanisms of dopamine-mediated behavioral plasticity in the striatum","volume":"105","author":"Cerovic","year":"2013","journal-title":"Neurobiol. Learn. Mem."},{"key":"B44","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.neuron.2007.10.001","article-title":"The story of Rett syndrome: from clinic to neurobiology","volume":"56","author":"Chahrour","year":"2007","journal-title":"Neuron"},{"key":"B45","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nchembio.78","article-title":"Identification of small molecules rescuing fragile X syndrome phenotypes in Drosophila","volume":"4","author":"Chang","year":"2008","journal-title":"Nat. Chem. Biol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.neuron.2005.12.027","article-title":"The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression","volume":"49","author":"Chang","year":"2006","journal-title":"Neuron"},{"key":"B47","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nature09582","article-title":"Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes","volume":"468","author":"Chao","year":"2010","journal-title":"Nature"},{"key":"B48","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2217\/fnl.12.79","article-title":"Recent progress in Rett syndrome and MeCP2 Dysfunction: assessment of potential treatment options","volume":"8","author":"Chapleau","year":"2013b","journal-title":"Future Neurol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"358","DOI":"10.2174\/15748847113086660069","article-title":"Evaluation of current pharmacological treatment options in the management of Rett syndrome: from the present to future therapeutic alternatives","volume":"8","author":"Chapleau","year":"2013a","journal-title":"Curr. Clin. Pharmacol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s11689-009-9027-6","article-title":"Modulation of dendritic spine development and plasticity by BDNF and vesicular trafficking: fundamental roles in neurodevelopmental disorders associated with mental retardation and autism","volume":"1","author":"Chapleau","year":"2009","journal-title":"J. Neurodev. Disord."},{"key":"B51","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/85906","article-title":"Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice","volume":"27","author":"Chen","year":"2001","journal-title":"Nat. Genet."},{"key":"B52","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1126\/science.1086446","article-title":"Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2","volume":"302","author":"Chen","year":"2003","journal-title":"Science"},{"key":"B53","doi-asserted-by":"publisher","first-page":"10977","DOI":"10.1523\/JNEUROSCI.1077-10.2010","article-title":"Physiological activation of synaptic Rac>PAK (p-21 activated kinase) signaling is defective in a mouse model of fragile X syndrome","volume":"30","author":"Chen","year":"2010","journal-title":"J. Neurosci."},{"key":"B54","doi-asserted-by":"publisher","first-page":"197491","DOI":"10.1155\/2012\/197491","article-title":"Astrocytes and developmental plasticity in fragile X","volume":"2012","author":"Cheng","year":"2012","journal-title":"Neural Plast."},{"key":"B55","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1146\/annurev.neuro.29.051605.112834","article-title":"Endocannabinoid-mediated synaptic plasticity in the CNS","volume":"29","author":"Chevaleyre","year":"2006","journal-title":"Annu. Rev. Neurosci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1177\/0883073807302611","article-title":"Memantine as adjunctive therapy in children diagnosed with autistic spectrum disorders: an observation of initial clinical response and maintenance tolerability","volume":"22","author":"Chez","year":"2007","journal-title":"J. Child Neurol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.pharmthera.2010.07.006","article-title":"Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders","volume":"128","author":"Chiu","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"B58","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1038\/sj.mp.4001167","article-title":"Role of altered brain serotonin mechanisms in autism","volume":"7","author":"Chugani","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"B59","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1042\/BST0380498","article-title":"Reversibility of functional deficits in experimental models of Rett syndrome","volume":"38","author":"Cobb","year":"2010","journal-title":"Biochem. Soc. Trans."},{"key":"B60","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.neuron.2011.08.022","article-title":"Genome-wide activity-dependent MeCP2 phosphorylation regulates nervous system development and function","volume":"72","author":"Cohen","year":"2011","journal-title":"Neuron"},{"key":"B61","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nrd1415","article-title":"GSK3 inhibitors: development and therapeutic potential","volume":"3","author":"Cohen","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"B62","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/106002809302700215","article-title":"Vigabatrin","volume":"27","author":"Connelly","year":"1993","journal-title":"Ann. Pharmacother."},{"key":"B63","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.neulet.2012.05.029","article-title":"Insulin-like growth factor 1 (IGF1) and its active peptide (1\u00e2\u20ac\u201c3)IGF1 enhance the expression of synaptic markers in neuronal circuits through different cellular mechanisms","volume":"520","author":"Corvin","year":"2012","journal-title":"Neurosci. Lett."},{"key":"B64","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.biopsych.2012.06.008","article-title":"Activation of 5-HT7 serotonin receptors reverses metabotropic glutamate receptor-mediated synaptic plasticity in wild-type and Fmr1 knockout mice, a model of Fragile X syndrome","volume":"72","author":"Costa","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"B65","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.1523\/JNEUROSCI.4477-10.2011","article-title":"Phosphoinositide-3-kinase activation controls synaptogenesis and spinogenesis in hippocampal neurons","volume":"31","author":"Cuesto","year":"2011","journal-title":"J. Neurosci."},{"key":"B66","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3389\/fncel.2013.00046","article-title":"Resilience to audiogenic seizures is associated with p-ERK1\/2 dephosphorylation in the subiculum of Fmr1 knockout mice","volume":"7","author":"Curia","year":"2013","journal-title":"Front. Cell. Neurosci."},{"key":"B67","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.neuroscience.2013.04.058","article-title":"Long-lasting effects of minocycline on behavior in young but not adult Fragile X mice","volume":"246","author":"Dansie","year":"2013","journal-title":"Neuroscience"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1038\/nn.3379","article-title":"The translation of translational control by FMRP: therapeutic targets for FXS","volume":"16","author":"Darnell","year":"2013","journal-title":"Nat. Neurosci."},{"key":"B69","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1749-6632.2012.06611.x","article-title":"The role of oxidative stress in Rett syndrome: an overview","volume":"1259","author":"De Felice","year":"2012","journal-title":"Ann. N Y Acad. Sci."},{"key":"B70","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nm.3193","article-title":"Progress toward treatments for synaptic defects in autism","volume":"19","author":"Delorme","year":"2013","journal-title":"Nat. Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.neuron.2012.12.018","article-title":"FMRP regulates neurotransmitter release and synaptic information transmission by modulating action potential duration via BK channels","volume":"77","author":"Deng","year":"2013","journal-title":"Neuron"},{"key":"B72","doi-asserted-by":"publisher","first-page":"14230","DOI":"10.1073\/pnas.1206093109","article-title":"Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome","volume":"109","author":"Deogracias","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B73","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.it.2012.10.002","article-title":"The role of microglia in brain maintenance: implications for Rett syndrome","volume":"34","author":"Derecki","year":"2013","journal-title":"Trends Immunol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/sj.mp.4001724","article-title":"Autism and the serotonin transporter: the long and short of it","volume":"10","author":"Devlin","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"B75","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.nbd.2008.04.002","article-title":"Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice","volume":"31","author":"de Vrij","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"B76","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.brainres.2006.08.115","article-title":"Decreased expression of the GABAA receptor in fragile X syndrome","volume":"1121","author":"D\u00e2\u20ac\u2122Hulst","year":"2006","journal-title":"Brain Res."},{"key":"B77","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.brainres.2008.11.075","article-title":"Expression of the GABAergic system in animal models for fragile X syndrome and fragile X associated tremor\/ataxia syndrome (FXTAS)","volume":"1253","author":"D\u00e2\u20ac\u2122Hulst","year":"2009","journal-title":"Brain Res."},{"key":"B78","doi-asserted-by":"publisher","first-page":"5671","DOI":"10.1073\/pnas.1219383110","article-title":"Rescue of fragile X syndrome phenotypes in Fmr1 KO mice by the small-molecule PAK inhibitor FRAX486","volume":"110","author":"Dolan","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1113\/jphysiol.2008.150722","article-title":"Role for metabotropic glutamate receptor 5 (mGluR5) in the pathogenesis of fragile X syndrome","volume":"586","author":"D\u00c3\u00b6len","year":"2008","journal-title":"J. Physiol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3389\/fncel.2014.00030","article-title":"Impaired activity-dependent neural circuit assembly and refinement in autism spectrum disorder genetic models","volume":"8","author":"Doll","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"B81","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.biopsych.2013.02.007","article-title":"Effects of intranasal oxytocin on the neural basis of face processing in autism spectrum disorder","volume":"74","author":"Domes","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.neuron.2012.12.004","article-title":"NMDA receptor regulation prevents regression of visual cortical function in the absence of Mecp2","volume":"76","author":"Durand","year":"2012","journal-title":"Neuron"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1002\/ajmg.a.36023","article-title":"High MMP-9 activity levels in fragile X syndrome are lowered by minocycline","volume":"161A","author":"Dziembowska","year":"2013","journal-title":"Am. J. Med. Genet. A"},{"key":"B84","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/hipo.20890","article-title":"NMDA receptor hypofunction in the dentate gyrus and impaired context discrimination in adult Fmr1 knockout mice","volume":"22","author":"Eadie","year":"2012","journal-title":"Hippocampus"},{"key":"B85","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nature11860","article-title":"Activity-dependent neuronal signalling and autism spectrum disorder","volume":"493","author":"Ebert","year":"2013","journal-title":"Nature"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.4088\/jcp.v67n0619h","article-title":"Memantine for disruptive behavior in autistic disorder","volume":"67","author":"Erickson","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1007\/s10803-009-0807-3","article-title":"Open-label memantine in fragile X syndrome","volume":"39","author":"Erickson","year":"2009","journal-title":"J. Autism Dev. Disord."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1007\/s10803-010-0988-9","article-title":"Brief report: acamprosate in fragile X syndrome","volume":"40","author":"Erickson","year":"2010","journal-title":"J. Autism Dev. Disord."},{"key":"B89","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00213-013-3022-z","article-title":"Impact of acamprosate on behavior and brain-derived neurotrophic factor: an open-label study in youth with fragile X syndrome","volume":"228","author":"Erickson","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"B90","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1002\/jnr.21273","article-title":"Matrix metalloproteinases in brain development and remodeling: synaptic functions and targets","volume":"85","author":"Ethell","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"B91","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.biopsych.2013.08.003","article-title":"Glycogen synthase kinase-3 inhibitors reverse deficits in long-term potentiation and cognition in fragile X mice","volume":"75","author":"Franklin","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"B92","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1021\/cn100032f","article-title":"Dopamine release and uptake impairments and behavioral alterations observed in mice that model fragile X mental retardation syndrome","volume":"1","author":"Fulks","year":"2010","journal-title":"ACS Chem. Neurosci."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj20110648","article-title":"MeCP2 and Rett syndrome: reversibility and potential avenues for therapy","volume":"439","author":"Gadalla","year":"2011","journal-title":"Biochem. J."},{"key":"B94","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3389\/fncel.2014.00070","article-title":"2-Methyl-6-(phenylethynyl) pyridine (MPEP) reverses maze learning and PSD-95 deficits in Fmr1 knock-out mice","volume":"8","author":"Gandhi","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"B95","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.bbr.2012.10.059","article-title":"Chronic administration of AFQ056\/Mavoglurant restores social behaviour in Fmr1 knockout mice","volume":"239","author":"Gantois","year":"2013","journal-title":"Behav. Brain Res."},{"key":"B96","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/ejhg.2008.61","article-title":"Fragile X syndrome","volume":"16","author":"Garber","year":"2008","journal-title":"Eur. J. Hum. Genet."},{"key":"B97","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nrn3249","article-title":"Regulation of neuronal GABA(B) receptor functions by subunit composition","volume":"13","author":"Gassmann","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"B98","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00221-013-3694-y","article-title":"The serotonin 5-HT7 receptors: two decades of research","volume":"230","author":"Gellynck","year":"2013","journal-title":"Exp. Brain Res."},{"key":"B99","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/sj.ejhg.5200618","article-title":"Parental origin of de novo MECP2 mutations in Rett syndrome","volume":"9","author":"Girard","year":"2001","journal-title":"Eur. J. Hum. Genet."},{"key":"B100","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nature11628","article-title":"Autism-related deficits via dysregulated eIF4E-dependent translational control","volume":"493","author":"Gkogkas","year":"2013","journal-title":"Nature"},{"key":"B101","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1212\/wnl.0b013e3181d6b852","article-title":"Epilepsy and the natural history of Rett syndrome","volume":"74","author":"Glaze","year":"2010","journal-title":"Neurology"},{"key":"B102","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.neuroscience.2012.06.052","article-title":"Synaptic NMDA receptor-mediated currents in anterior piriform cortex are reduced in the adult fragile X mouse","volume":"221","author":"Gocel","year":"2012","journal-title":"Neuroscience"},{"key":"B103","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1124\/pr.110.003053","article-title":"Therapeutic implications for striatal-enriched protein tyrosine phosphatase (STEP) in neuropsychiatric disorders","volume":"64","author":"Goebel-Goody","year":"2012b","journal-title":"Pharmacol. Rev."},{"key":"B104","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/978-3-642-21649-7_12","article-title":"Taking STEPs forward to understand fragile X syndrome","volume":"54","author":"Goebel-Goody","year":"2012","journal-title":"Results Probl. Cell Differ."},{"key":"B105","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/j.1601-183x.2012.00781.x","article-title":"Genetic manipulation of STEP reverses behavioral abnormalities in a fragile X syndrome mouse model","volume":"11","author":"Goebel-Goody","year":"2012a","journal-title":"Genes Brain Behav."},{"key":"B106","doi-asserted-by":"publisher","first-page":"20953","DOI":"10.1073\/pnas.1312857110","article-title":"Oxytocin enhances brain function in children with autism","volume":"110","author":"Gordon","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B107","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.pneurobio.2007.02.001","article-title":"Structure and functions of the human amyloid precursor protein: the whole is more than the sum of its parts","volume":"82","author":"Gralle","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"336","DOI":"10.2119\/molmed.2011.00363","article-title":"Excess protein synthesis in FXS patient lymphoblastoid cells can be rescued with a p110beta-selective inhibitor","volume":"18","author":"Gross","year":"2012","journal-title":"Mol. Med."},{"key":"B109","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fnmol.2014.00012","article-title":"Neuron-specific regulation of class I PI3K catalytic subunits and their dysfunction in brain disorders","volume":"7","author":"Gross","year":"2014","journal-title":"Front. Mol. Neurosci."},{"key":"B110","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/npp.2011.137","article-title":"Therapeutic strategies in fragile X syndrome: dysregulated mGluR signaling and beyond","volume":"37","author":"Gross","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"B111","doi-asserted-by":"publisher","first-page":"10624","DOI":"10.1523\/jneurosci.0402-10.2010","article-title":"Excess phosphoinositide 3-kinase subunit synthesis and activity as a novel therapeutic target in fragile X syndrome","volume":"30","author":"Gross","year":"2010","journal-title":"J. Neurosci."},{"key":"B112","doi-asserted-by":"publisher","first-page":"5693","DOI":"10.1523\/jneurosci.6661-10.2011","article-title":"Fragile X mental retardation protein regulates protein expression and mRNA translation of the potassium channel Kv4.2","volume":"31","author":"Gross","year":"2011","journal-title":"J. Neurosci."},{"key":"B113","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/hmg\/ddr501","article-title":"Inhibition of GSK3beta improves hippocampus-dependent learning and rescues neurogenesis in a mouse model of fragile X syndrome","volume":"21","author":"Guo","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"B114","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1146\/annurev-cellbio-092910-154121","article-title":"The role of MeCP2 in the brain","volume":"27","author":"Guy","year":"2011","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1126\/science.1138389","article-title":"Reversal of neurological defects in a mouse model of Rett syndrome","volume":"315","author":"Guy","year":"2007","journal-title":"Science"},{"key":"B116","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/85899","article-title":"A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome","volume":"27","author":"Guy","year":"2001","journal-title":"Nat. Genet."},{"key":"B117","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/ana.410140412","article-title":"A progressive syndrome of autism, dementia, ataxia and loss of purposeful hand use in girls: Rett\u00e2\u20ac\u2122s syndrome: report of 35 cases","volume":"14","author":"Hagberg","year":"1983","journal-title":"Ann. Neurol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"e294","DOI":"10.4088\/jcp.13r08714","article-title":"Translating molecular advances in fragile X syndrome into therapy: a review","volume":"75","author":"Hagerman","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"B119","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/(sici)1096-8628(19990402)83:4313::aid-ajmg153.0.co;2-f","article-title":"Fragile X syndrome and selective mutism","volume":"83","author":"Hagerman","year":"1999","journal-title":"Am. J. Med. Genet."},{"key":"B120","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/yco.0000000000000131","article-title":"Treatment of the psychiatric problems associated with fragile X syndrome","volume":"28","author":"Hagerman","year":"2015","journal-title":"Curr. Opin. Psychiatry"},{"key":"B121","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.psyneuen.2011.07.020","article-title":"Effects of intranasal oxytocin on social anxiety in males with fragile X syndrome","volume":"37","author":"Hall","year":"2012","journal-title":"Psychoneuroendocrinology"},{"key":"B122","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/aur.1288","article-title":"Serotonin hypothesis of autism: implications for selective serotonin reuptake inhibitor use during pregnancy","volume":"6","author":"Harrington","year":"2013","journal-title":"Autism Res."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1101\/gad.1212704","article-title":"Upstream and downstream of mTOR","volume":"18","author":"Hay","year":"2004","journal-title":"Genes Dev."},{"key":"B124","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.neuron.2004.05.003","article-title":"Altered cortical synaptic morphology and impaired memory consolidation in forebrain-specific dominant-negative PAK transgenic mice","volume":"42","author":"Hayashi","year":"2004","journal-title":"Neuron"},{"key":"B125","doi-asserted-by":"publisher","first-page":"11489","DOI":"10.1073\/pnas.0705003104","article-title":"Inhibition of p21-activated kinase rescues symptoms of fragile X syndrome in mice","volume":"104","author":"Hayashi","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B126","doi-asserted-by":"publisher","first-page":"14223","DOI":"10.1523\/jneurosci.3157-11.2011","article-title":"Altered neocortical rhythmic activity states in Fmr1 KO mice are due to enhanced mGluR5 signaling and involve changes in excitatory circuitry","volume":"31","author":"Hays","year":"2011","journal-title":"J. Neurosci."},{"key":"B127","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1523\/jneurosci.4447-13.2014","article-title":"The developmental switch in GABA polarity is delayed in fragile X mice","volume":"34","author":"He","year":"2014","journal-title":"J. Neurosci."},{"key":"B128","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13023-014-0124-6","article-title":"Rescue of fragile X syndrome phenotypes in Fmr1 KO mice by a BKCa channel opener molecule","volume":"9","author":"Hebert","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"key":"B129","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1146\/annurev.physiol.010908.163149","article-title":"Endocannabinoid signaling and long-term synaptic plasticity","volume":"71","author":"Heifets","year":"2009","journal-title":"Annu. Rev. Physiol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"152ra128","DOI":"10.1126\/scitranslmed.3004218","article-title":"Reversal of disease-related pathologies in the fragile X mouse model by selective activation of GABAB receptors with arbaclofen","volume":"4","author":"Henderson","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"B131","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11689-008-9001-8","article-title":"A solution to limitations of cognitive testing in children with intellectual disabilities: the case of fragile X syndrome","volume":"1","author":"Hessl","year":"2009","journal-title":"J. Neurodev. Disord."},{"key":"B132","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.bbr.2012.01.031","article-title":"Pharmacological treatment of fragile X syndrome with GABAergic drugs in a knockout mouse model","volume":"229","author":"Heulens","year":"2012","journal-title":"Behav. Brain Res."},{"key":"B133","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.tins.2009.11.003","article-title":"mTOR signaling: at the crossroads of plasticity, memory and disease","volume":"33","author":"Hoeffer","year":"2010","journal-title":"Trends Neurosci."},{"key":"B134","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/j.1601-183x.2012.00768.x","article-title":"Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome","volume":"11","author":"Hoeffer","year":"2012","journal-title":"Genes Brain Behav."},{"key":"B135","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/sj.npp.1300627","article-title":"A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism","volume":"30","author":"Hollander","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"B136","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1176\/appi.ajp.2011.10050764","article-title":"A double-blind placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disorders","volume":"169","author":"Hollander","year":"2012","journal-title":"Am. J. Psychiatry"},{"key":"B137","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1111\/j.1460-9568.2006.04859.x","article-title":"Signalling mechanisms mediated by the phosphoinositide 3-kinase\/Akt cascade in synaptic plasticity and memory in the rat","volume":"23","author":"Horwood","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"B138","doi-asserted-by":"publisher","first-page":"7847","DOI":"10.1523\/jneurosci.1496-08.2008","article-title":"Ras signaling mechanisms underlying impaired GluR1-dependent plasticity associated with fragile X syndrome","volume":"28","author":"Hu","year":"2008","journal-title":"J. Neurosci."},{"key":"B139","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1146\/annurev-genom-091212-153431","article-title":"The genetic landscapes of autism spectrum disorders","volume":"14","author":"Huguet","year":"2013","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"B140","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/nrn3320","article-title":"Synaptic circuit remodelling by matrix metalloproteinases in health and disease","volume":"13","author":"Huntley","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"B141","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.neulet.2008.10.006","article-title":"Minocycline increases phosphorylation and membrane insertion of neuronal GluR1 receptors","volume":"447","author":"Imbesi","year":"2008","journal-title":"Neurosci. Lett."},{"key":"B143","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s00213-013-3289-0","article-title":"The challenges of clinical trials in fragile X syndrome","volume":"231","author":"Jacquemont","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"B142","doi-asserted-by":"publisher","first-page":"64ra61","DOI":"10.1126\/scitranslmed.3001708","article-title":"Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056","volume":"3","author":"Jacquemont","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"B144","doi-asserted-by":"publisher","first-page":"18234","DOI":"10.1523\/JNEUROSCI.2207-13.2013","article-title":"The fragile X mental retardation protein regulates matrix metalloproteinase 9 mRNA at synapses","volume":"33","author":"Janusz","year":"2013","journal-title":"J. Neurosci."},{"key":"B145","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/s0301-0082(03)00085-6","article-title":"Dopamine: a potential substrate for synaptic plasticity and memory mechanisms","volume":"69","author":"Jay","year":"2003","journal-title":"Prog. Neurobiol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.2174\/1389450110607011421","article-title":"Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions","volume":"7","author":"Jope","year":"2006","journal-title":"Curr. Drug Targets"},{"key":"B147","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/neu.10201","article-title":"The expression of methyl CpG binding factor MeCP2 correlates with cellular differentiation in the developing rat brain and in cultured cells","volume":"55","author":"Jung","year":"2003","journal-title":"J. Neurobiol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/ncomms2045","article-title":"Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome","volume":"3","author":"Jung","year":"2012","journal-title":"Nat. Commun."},{"key":"B149","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/978-3-642-45106-5_18","article-title":"Brain-derived neurotrophic factor and Rett syndrome","volume":"220","author":"Katz","year":"2014","journal-title":"Handb. Exp. Pharmacol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1242\/dmm.011007","article-title":"Preclinical research in Rett syndrome: setting the foundation for translational success","volume":"5","author":"Katz","year":"2012","journal-title":"Dis. Model. Mech."},{"key":"B151","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/s0092-8674(04)00115-1","article-title":"Translational control by MAPK signaling in long-term synaptic plasticity and memory","volume":"116","author":"Kelleher","year":"2004","journal-title":"Cell"},{"key":"B152","doi-asserted-by":"publisher","first-page":"4596","DOI":"10.1073\/pnas.1311141111","article-title":"Safety, pharmacokinetics and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndrome","volume":"111","author":"Khwaja","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B153","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3389\/fncel.2014.00209","article-title":"Emerging role of the KCNT1 Slack channel in intellectual disability","volume":"8","author":"Kim","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"B154","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1073\/pnas.0800257105","article-title":"Aberrant early-phase ERK inactivation impedes neuronal function in fragile X syndrome","volume":"105","author":"Kim","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B155","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/gbb.12071","article-title":"Lithium treatment alleviates impaired cognition in a mouse model of fragile X syndrome","volume":"12","author":"King","year":"2013","journal-title":"Genes Brain Behav."},{"key":"B156","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.tibs.2005.12.008","article-title":"Genomic DNA methylation: the mark and its mediators","volume":"31","author":"Klose","year":"2006","journal-title":"Trends Biochem. Sci."},{"key":"B157","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fnbeh.2014.00031","article-title":"Evolution of oxytocin pathways in the brain of vertebrates","volume":"8","author":"Knobloch","year":"2014","journal-title":"Front. Behav. Neurosci."},{"key":"B158","doi-asserted-by":"publisher","first-page":"407","DOI":"10.4088\/jcp.v67n0311","article-title":"Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability","volume":"67","author":"Kolevzon","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"B159","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.cellsig.2008.11.001","article-title":"PAK signalling in neuronal physiology","volume":"21","author":"Kreis","year":"2009","journal-title":"Cell. Signal."},{"key":"B160","doi-asserted-by":"publisher","first-page":"13860","DOI":"10.1523\/JNEUROSCI.2159-12.2012","article-title":"Brain activity mapping in Mecp2 mutant mice reveals functional deficits in forebrain circuits, including key nodes in the default mode network, that are reversed with ketamine treatment","volume":"32","author":"Kron","year":"2012","journal-title":"J. Neurosci."},{"key":"B161","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1242\/dmm.016030","article-title":"A BDNF loop-domain mimetic acutely reverses spontaneous apneas and respiratory abnormalities during behavioral arousal in a mouse model of Rett syndrome","volume":"7","author":"Kron","year":"2014","journal-title":"Dis. Model. Mech."},{"key":"B162","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1073\/pnas.1013855108","article-title":"Cognitive dysfunction and prefrontal synaptic abnormalities in a mouse model of fragile X syndrome","volume":"108","author":"Krueger","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B163","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.tins.2013.11.005","article-title":"A de novo convergence of autism genetics and molecular neuroscience","volume":"37","author":"Krumm","year":"2014","journal-title":"Trends Neurosci."},{"key":"B164","doi-asserted-by":"publisher","first-page":"32004","DOI":"10.1074\/jbc.M113.475863","article-title":"Agonist-dependent signaling by group I metabotropic glutamate receptors is regulated by association with lipid domains","volume":"288","author":"Kumari","year":"2013","journal-title":"J. Biol. Chem."},{"key":"B165","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(13)61539-1","article-title":"Autism","volume":"383","author":"Lai","year":"2014","journal-title":"Lancet"},{"key":"B166","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nature11556","article-title":"A call for transparent reporting to optimize the predictive value of preclinical research","volume":"490","author":"Landis","year":"2012","journal-title":"Nature"},{"key":"B167","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1093\/hmg\/10.17.1729","article-title":"Quantitative localization of heterogeneous methyl-CpG-binding protein 2 (MeCP2) expression phenotypes in normal and Rett syndrome brain by laser scanning cytometry","volume":"10","author":"LaSalle","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"B168","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.jpeds.2005.10.037","article-title":"Rett syndrome in Australia: a review of the epidemiology","volume":"148","author":"Laurvick","year":"2006","journal-title":"J. Pediatr."},{"key":"B169","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1124\/jpet.103.053694","article-title":"Chronic elevation of brain-derived neurotrophic factor by ampakines","volume":"307","author":"Lauterborn","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B170","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.neuron.2011.09.033","article-title":"Bidirectional regulation of dendritic voltage-gated potassium channels by the fragile X mental retardation protein","volume":"72","author":"Lee","year":"2011","journal-title":"Neuron"},{"key":"B171","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.conb.2012.03.010","article-title":"Fragile X syndrome: mechanistic insights and therapeutic avenues regarding the role of potassium channels","volume":"22","author":"Lee","year":"2012","journal-title":"Curr. Opin. Neurobiol."},{"key":"B172","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/DBP.0b013e318287cd17","article-title":"A randomized double-blind, placebo-controlled trial of minocycline in children and adolescents with fragile x syndrome","volume":"34","author":"Leigh","year":"2013","journal-title":"J. Dev. Behav. Pediatr."},{"key":"B173","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/0887-8994(89)90049-0","article-title":"Rett syndrome: biogenic amines and metabolites in postmortem brain","volume":"5","author":"Lekman","year":"1989","journal-title":"Pediatr. Neurol."},{"key":"B174","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.neuron.2012.09.013","article-title":"Serotonin in the modulation of neural plasticity and networks: implications for neurodevelopmental disorders","volume":"76","author":"Lesch","year":"2012","journal-title":"Neuron"},{"key":"B175","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.nbd.2011.01.022","article-title":"AFQ056, a new mGluR5 antagonist for treatment of fragile X syndrome","volume":"42","author":"Levenga","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"B176","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.neuropharm.2013.03.024","article-title":"BDNF deregulation in Rett syndrome","volume":"76","author":"Li","year":"2014","journal-title":"Neuropharmacology"},{"key":"B177","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1101\/gad.232470.113","article-title":"Pharmacological rescue of Ras signaling, GluA1-dependent synaptic plasticity and learning deficits in a fragile X model","volume":"28","author":"Lim","year":"2014","journal-title":"Genes Dev."},{"key":"B178","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.neuron.2013.01.009","article-title":"Fragile X syndrome therapeutics: translation, meet translational medicine","volume":"77","author":"Lipton","year":"2013","journal-title":"Neuron"},{"key":"B179","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1038\/npp.2010.19","article-title":"Abnormal mGlu 5 receptor\/endocannabinoid coupling in mice lacking FMRP and BC1 RNA","volume":"35","author":"Maccarrone","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"B180","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.neuroscience.2010.03.065","article-title":"Diminished prevalence but preserved synaptic distribution of N-methyl-D-aspartate receptor subunits in the methyl CpG binding protein 2(MeCP2)-null mouse brain","volume":"168","author":"Maliszewska-Cyna","year":"2010","journal-title":"Neuroscience"},{"key":"B181","doi-asserted-by":"publisher","first-page":"200","DOI":"10.2174\/156720510791050957","article-title":"Fragile X syndrome and Alzheimer\u00e2\u20ac\u2122s disease: another story about APP and beta-amyloid","volume":"7","author":"Malter","year":"2010","journal-title":"Curr. Alzheimer Res."},{"key":"B182","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.cell.2010.10.016","article-title":"A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells","volume":"143","author":"Marchetto","year":"2010","journal-title":"Cell"},{"key":"B183","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1126\/science.1090842","article-title":"DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation","volume":"302","author":"Martinowich","year":"2003","journal-title":"Science"},{"key":"B184","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1172\/JCI41356","article-title":"Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents","volume":"120","author":"Massa","year":"2010","journal-title":"J. Clin. Invest."},{"key":"B185","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s12035-011-8175-3","article-title":"Role of the 5-HT7 receptor in the central nervous system: from current status to future perspectives","volume":"43","author":"Matthys","year":"2011","journal-title":"Mol. Neurobiol."},{"key":"B186","doi-asserted-by":"publisher","first-page":"113ra125","DOI":"10.1126\/scitranslmed.3002982","article-title":"Pathogenesis of lethal cardiac arrhythmias in Mecp2 mutant mice: implication for therapy in Rett syndrome","volume":"3","author":"McCauley","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"B187","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1152\/jn.00510.2007","article-title":"Muscarinic receptor dependent long-term depression in rat visual cortex is PKC independent but requires ERK1\/2 activation and protein synthesis","volume":"98","author":"McCoy","year":"2007","journal-title":"J. Neurophysiol."},{"key":"B188","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/mp.2009.80","article-title":"The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation","volume":"15","author":"McEwen","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"B189","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1152\/jn.00826.2007","article-title":"Early defects of GABAergic synapses in the brain stem of a MeCP2 mouse model of Rett syndrome","volume":"99","author":"Medrihan","year":"2008","journal-title":"J. Neurophysiol."},{"key":"B190","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1056\/NEJMra1114194","article-title":"Genomics, intellectual disability and autism","volume":"366","author":"Mefford","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"B191","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nrn3044","article-title":"Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine","volume":"12","author":"Meyer-Lindenberg","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"B192","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.biopsych.2013.05.038","article-title":"Chronic metabotropic glutamate receptor 5 inhibition corrects local alterations of brain activity and improves cognitive performance in fragile X mice","volume":"75","author":"Michalon","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"B193","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.neuron.2012.03.009","article-title":"Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice","volume":"74","author":"Michalon","year":"2012","journal-title":"Neuron"},{"key":"B194","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.neuropharm.2008.09.017","article-title":"Elevated glycogen synthase kinase-3 activity in fragile X mice: key metabolic regulator with evidence for treatment potential","volume":"56","author":"Min","year":"2009","journal-title":"Neuropharmacology"},{"key":"B195","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3389\/fnmol.2011.00035","article-title":"Glycogen synthase kinase-3: a promising therapeutic target for fragile x syndrome","volume":"4","author":"Mines","year":"2011","journal-title":"Front. Mol. Neurosci."},{"key":"B196","doi-asserted-by":"publisher","first-page":"e9706","DOI":"10.1371\/journal.pone.0009706","article-title":"GSK3 influences social preference and anxiety-related behaviors during social interaction in a mouse model of fragile X syndrome and autism","volume":"5","author":"Mines","year":"2010","journal-title":"PLoS One"},{"key":"B197","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1177\/1073858409341085","article-title":"Homeostatic regulation of neuronal excitability by K(+) channels in normal and diseased brains","volume":"16","author":"Misonou","year":"2010","journal-title":"Neuroscientist"},{"key":"B198","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.gde.2006.04.009","article-title":"MeCP2 dysfunction in Rett syndrome and related disorders","volume":"16","author":"Moretti","year":"2006","journal-title":"Curr. Opin. Genet. Dev."},{"key":"B199","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.neuropharm.2012.06.005","article-title":"Role of metabotropic glutamate receptors in persistent forms of hippocampal plasticity and learning","volume":"66","author":"Mukherjee","year":"2013","journal-title":"Neuropharmacology"},{"key":"B200","doi-asserted-by":"publisher","first-page":"5040","DOI":"10.1523\/jneurosci.2896-12.2013","article-title":"Postsynaptic density scaffold SAP102 regulates cortical synapse development through EphB and PAK signaling pathway","volume":"33","author":"Murata","year":"2013","journal-title":"J. Neurosci."},{"key":"B201","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.gde.2013.02.003","article-title":"Recent developments in the genetics of autism spectrum disorders","volume":"23","author":"Murdoch","year":"2013","journal-title":"Curr. Opin. Genet. Dev."},{"key":"B202","doi-asserted-by":"publisher","first-page":"15537","DOI":"10.1073\/pnas.0707484104","article-title":"Fragile X mental retardation protein deficiency leads to excessive mGluR5-dependent internalization of AMPA receptors","volume":"104","author":"Nakamoto","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B203","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1016\/j.febslet.2013.05.010","article-title":"The amyloid precursor protein: a biochemical enigma in brain development, function and disease","volume":"587","author":"Nalivaeva","year":"2013","journal-title":"FEBS Lett."},{"key":"B204","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3410\/f.718020287.793478774","article-title":"Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex","volume":"393","author":"Nan","year":"1998","journal-title":"Nature"},{"key":"B205","doi-asserted-by":"publisher","first-page":"18478","DOI":"10.1074\/jbc.c800055200","article-title":"S6K1 phosphorylates and regulates fragile X mental retardation protein (FMRP) with the neuronal protein synthesis-dependent mammalian target of rapamycin (mTOR) signaling cascade","volume":"283","author":"Narayanan","year":"2008","journal-title":"J. Biol. Chem."},{"key":"B206","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1002\/ana.22124","article-title":"Rett syndrome: revised diagnostic criteria and nomenclature","volume":"68","author":"Neul","year":"2010","journal-title":"Ann. Neurol."},{"key":"B207","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1866-1955-6-20","article-title":"Developmental delay in Rett syndrome: data from the natural history study","volume":"6","author":"Neul","year":"2014","journal-title":"J. Neurodev. Disord."},{"key":"B208","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1111\/j.1365-2826.2008.01726.x","article-title":"Brain oxytocin: a key regulator of emotional and social behaviours in both females and males","volume":"20","author":"Neumann","year":"2008","journal-title":"J. Neuroendocrinol."},{"key":"B209","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.tins.2012.08.004","article-title":"Balance of brain oxytocin and vasopressin: implications for anxiety, depression and social behaviors","volume":"35","author":"Neumann","year":"2012","journal-title":"Trends Neurosci."},{"key":"B210","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/01.jcp.0000270082.30500.69","article-title":"Glutamate antagonists seem to be slightly effective in psychopharmacologic treatment of autism","volume":"27","author":"Niederhofer","year":"2007","journal-title":"J. Clin. Psychopharmacol."},{"key":"B211","doi-asserted-by":"publisher","first-page":"10912","DOI":"10.1523\/jneurosci.1869-07.2007","article-title":"Brain-derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome","volume":"27","author":"Ogier","year":"2007","journal-title":"J. Neurosci."},{"key":"B212","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1159\/000332884","article-title":"The GABA(A) receptor agonist THIP ameliorates specific behavioral deficits in the mouse model of fragile X syndrome","volume":"33","author":"Olmos-Serrano","year":"2011","journal-title":"Dev. Neurosci."},{"key":"B213","doi-asserted-by":"publisher","first-page":"9929","DOI":"10.1523\/jneurosci.1714-10.2010","article-title":"Defective GABAergic neurotransmission and pharmacological rescue of neuronal hyperexcitability in the amygdala in a mouse model of fragile X syndrome","volume":"30","author":"Olmos-Serrano","year":"2010","journal-title":"J. Neurosci."},{"key":"B214","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2174\/1568007043337508","article-title":"AMPA receptor potentiators for the treatment of CNS disorders","volume":"3","author":"O\u00e2\u20ac\u2122Neill","year":"2004","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"key":"B215","doi-asserted-by":"publisher","first-page":"603","DOI":"10.2174\/138945007780618517","article-title":"AMPA receptor potentiators: application for depression and Parkinson\u00e2\u20ac\u2122s disease","volume":"8","author":"O\u00e2\u20ac\u2122Neill","year":"2007","journal-title":"Curr. Drug Targets"},{"key":"B216","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.neuron.2012.01.034","article-title":"Lovastatin corrects excess protein synthesis and prevents epileptogenesis in a mouse model of fragile X syndrome","volume":"77","author":"Osterweil","year":"2013","journal-title":"Neuron"},{"key":"B217","doi-asserted-by":"publisher","first-page":"15616","DOI":"10.1523\/jneurosci.3888-10.2010","article-title":"Hypersensitivity to mGluR5 and ERK1\/2 leads to excessive protein synthesis in the hippocampus of a mouse model of fragile X syndrome","volume":"30","author":"Osterweil","year":"2010","journal-title":"J. Neurosci."},{"key":"B218","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1111\/j.1460-9568.2011.07831.x","article-title":"DAGL-dependent endocannabinoid signalling: roles in axonal pathfinding, synaptic plasticity and adult neurogenesis","volume":"34","author":"Oudin","year":"2011","journal-title":"Eur. J. Neurosci."},{"key":"B219","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1002\/glia.20573","article-title":"Developmental expression of FMRP in the astrocyte lineage: implications for fragile X syndrome","volume":"55","author":"Pacey","year":"2007","journal-title":"Glia"},{"key":"B220","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1124\/mol.109.056127","article-title":"Increased GABA(B) receptor-mediated signaling reduces the susceptibility of fragile X knockout mice to audiogenic seizures","volume":"76","author":"Pacey","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"B221","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1124\/jpet.111.183327","article-title":"Subchronic administration and combination metabotropic glutamate and GABAB receptor drug therapy in fragile X syndrome","volume":"338","author":"Pacey","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B222","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1159\/000329420","article-title":"Fragile X syndrome: the GABAergic system and circuit dysfunction","volume":"33","author":"Paluszkiewicz","year":"2011","journal-title":"Dev. Neurosci."},{"key":"B223","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/1471-2377-10-91","article-title":"Open-label add-on treatment trial of minocycline in fragile X syndrome","volume":"10","author":"Paribello","year":"2010","journal-title":"BMC Neurol."},{"key":"B224","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1113\/jphysiol.2012.241067","article-title":"Dampened dopamine-mediated neuromodulation in prefrontal cortex of fragile X mice","volume":"591","author":"Paul","year":"2013","journal-title":"J. Physiol."},{"key":"B225","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1146\/annurev.genom.8.080706.092249","article-title":"The pathophysiology of fragile x syndrome","volume":"8","author":"Penagarikano","year":"2007","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"B226","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1177\/0883073807308715","article-title":"Rett syndrome: North American database","volume":"22","author":"Percy","year":"2007","journal-title":"J. Child Neurol."},{"key":"B227","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/ana.22154","article-title":"Rett syndrome diagnostic criteria: lessons from the natural history study","volume":"68","author":"Percy","year":"2010","journal-title":"Ann. Neurol."},{"key":"B228","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.neuron.2012.08.036","article-title":"Acetylcholine as a neuromodulator: cholinergic signaling shapes nervous system function and behavior","volume":"76","author":"Picciotto","year":"2012","journal-title":"Neuron"},{"key":"B229","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1113\/jphysiol.2008.160929","article-title":"Synaptic ionotropic glutamate receptors and plasticity are developmentally altered in the CA1 field of Fmr1 knockout mice","volume":"587","author":"Pilpel","year":"2009","journal-title":"J. Physiol."},{"key":"B230","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1093\/hmg\/ddt111","article-title":"Insulinotropic treatments exacerbate metabolic syndrome in mice lacking MeCP2 function","volume":"22","author":"Pitcher","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"B231","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s00213-012-2947-y","article-title":"Rescue of dendritic spine phenotype in Fmr1 KO mice with the mGluR5 antagonist AFQ056\/Mavoglurant","volume":"231","author":"Pop","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"B232","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1002\/jnr.22409","article-title":"Aminoglycoside-mediated partial suppression of MECP2 nonsense mutations responsible for Rett syndrome in vitro","volume":"88","author":"Popescu","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"B233","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1098\/rstb.2008.0143","article-title":"Enhanced activity of human serotonin transporter variants associated with autism","volume":"364","author":"Prasad","year":"2009","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"B234","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1089\/cap.2013.0040","article-title":"Oxytocin and autism: a systematic review of randomized controlled trials","volume":"24","author":"Preti","year":"2014","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"B235","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.neuropharm.2010.02.011","article-title":"The functional neurophysiology of the amyloid precursor protein (APP) processing pathway","volume":"59","author":"Randall","year":"2010","journal-title":"Neuropharmacology"},{"key":"B236","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1523\/JNEUROSCI.20-03-00969.2000","article-title":"Metabotropic glutamate receptors trigger homosynaptic protein synthesis to prolong long-term potentiation","volume":"20","author":"Raymond","year":"2000","journal-title":"J. Neurosci."},{"key":"B237","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/j.1365-2788.2005.00713.x","article-title":"Blink rate in boys with fragile X syndrome: preliminary evidence for altered dopamine function","volume":"49","author":"Roberts","year":"2005","journal-title":"J. Intellect. Disabil. Res."},{"key":"B238","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s12311-013-0462-2","article-title":"Reorganization of circuits underlying cerebellar modulation of prefrontal cortical dopamine in mouse models of autism spectrum disorder","volume":"12","author":"Rogers","year":"2013","journal-title":"Cerebellum"},{"key":"B239","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrg3585","article-title":"The role of de novo mutations in the genetics of autism spectrum disorders","volume":"15","author":"Ronemus","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"B240","doi-asserted-by":"publisher","first-page":"pe6","DOI":"10.1126\/stke.15pe6","article-title":"Metabotropic glutamate receptors and fragile x mental retardation protein: partners in translational regulation at the synapse","volume":"1","author":"Ronesi","year":"2008a","journal-title":"Sci. Signal."},{"key":"B241","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1523\/jneurosci.5019-07.2008","article-title":"Homer interactions are necessary for metabotropic glutamate receptor-induced long-term depression and translational activation","volume":"28","author":"Ronesi","year":"2008b","journal-title":"J. Neurosci."},{"key":"B242","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.brainres.2011.12.041","article-title":"Minocycline treatment reverses ultrasonic vocalization production deficit in a mouse model of Fragile X syndrome","volume":"1439","author":"Rotschafer","year":"2012","journal-title":"Brain Res."},{"key":"B243","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1111\/j.1460-9568.2007.05466.x","article-title":"Treatment with desipramine improves breathing and survival in a mouse model for Rett syndrome","volume":"25","author":"Roux","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"B244","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.neulet.2008.09.045","article-title":"Tyrosine hydroxylase deficit in the chemoafferent and the sympathoadrenergic pathways of the Mecp2 deficient mouse","volume":"447","author":"Roux","year":"2008","journal-title":"Neurosci. Lett."},{"key":"B245","doi-asserted-by":"publisher","first-page":"7951","DOI":"10.1523\/jneurosci.0169-11.2011","article-title":"Complexities of Rett syndrome and MeCP2","volume":"31","author":"Samaco","year":"2011","journal-title":"J. Neurosci."},{"key":"B246","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1146\/annurev-pathol-011811-132457","article-title":"Molecular mechanisms of fragile X syndrome: a twenty-year perspective","volume":"7","author":"Santoro","year":"2012","journal-title":"Annu. Rev. Pathol."},{"key":"B247","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/ajmg.a.20571","article-title":"Phenotypic manifestations of MECP2 mutations in classical and atypical Rett syndrome","volume":"126A","author":"Schanen","year":"2004","journal-title":"Am. J. Med. Genet. A"},{"key":"B248","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1038\/npp.2014.78","article-title":"An oxytocin-induced facilitation of neural and emotional responses to social touch correlates inversely with autism traits","volume":"39","author":"Scheele","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"B249","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1523\/JNEUROSCI.0865-11.2012","article-title":"A TrkB small molecule partial agonist rescues TrkB phosphorylation deficits and improves respiratory function in a mouse model of Rett syndrome","volume":"32","author":"Schmid","year":"2012","journal-title":"J. Neurosci."},{"key":"B250","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1111\/jnc.12453","article-title":"c-Jun N-terminal kinase regulates mGluR-dependent expression of post-synaptic FMRP target proteins","volume":"127","author":"Schmit","year":"2013","journal-title":"J. Neurochem."},{"key":"B251","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2004.05.006","article-title":"The principal features and mechanisms of dopamine modulation in the prefrontal cortex","volume":"74","author":"Seamans","year":"2004","journal-title":"Prog. Neurobiol."},{"key":"B252","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1146\/annurev.neuro.19.1.463","article-title":"Intracellular signaling pathways activated by neurotrophic factors","volume":"19","author":"Segal","year":"1996","journal-title":"Annu. Rev. Neurosci."},{"key":"B253","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/hmg\/11.2.115","article-title":"Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation","volume":"11","author":"Shahbazian","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"B254","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1523\/jneurosci.3696-09.2010","article-title":"Dysregulation of mTOR signaling in fragile X syndrome","volume":"30","author":"Sharma","year":"2010","journal-title":"J. Neurosci."},{"key":"B255","doi-asserted-by":"publisher","first-page":"9867","DOI":"10.1523\/jneurosci.1162-14.2014","article-title":"Genetic removal of matrix metalloproteinase 9 rescues the symptoms of fragile x syndrome in a mouse model","volume":"34","author":"Sidhu","year":"2014","journal-title":"J. Neurosci."},{"key":"B256","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1756-6606-6-15","article-title":"Fragile X mental retardation protein and synaptic plasticity","volume":"6","author":"Sidorov","year":"2013","journal-title":"Mol. Brain"},{"key":"B257","doi-asserted-by":"publisher","first-page":"40224","DOI":"10.1074\/jbc.R112.386664","article-title":"Structure, function and modulation of GABA(A) receptors","volume":"287","author":"Sigel","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B258","doi-asserted-by":"publisher","first-page":"124548","DOI":"10.1155\/2012\/124548","article-title":"Matrix metalloproteinases and minocycline: therapeutic avenues for fragile X syndrome","volume":"2012","author":"Siller","year":"2012","journal-title":"Neural Plast."},{"key":"B259","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2013.04.002","article-title":"Fmr1 deletion enhances and ultimately desensitizes CB(1) signaling in autaptic hippocampal neurons","volume":"56","author":"Straiker","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"B260","doi-asserted-by":"publisher","first-page":"10263","DOI":"10.1523\/jneurosci.1125-10.2010","article-title":"Fragile X mental retardation protein is required for rapid experience-dependent regulation of the potassium channel Kv3.1b","volume":"30","author":"Strumbos","year":"2010","journal-title":"J. Neurosci."},{"key":"B261","doi-asserted-by":"publisher","first-page":"S137","DOI":"10.1038\/sj.bjp.0707659","article-title":"Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis","volume":"153","author":"Sugden","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"B262","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.conb.2009.10.003","article-title":"Dopamine and synaptic plasticity in dorsal striatal circuits controlling action selection","volume":"19","author":"Surmeier","year":"2009","journal-title":"Curr. Opin. Neurobiol."},{"key":"B263","doi-asserted-by":"publisher","first-page":"11591","DOI":"10.1073\/pnas.1002262107","article-title":"Characterization and reversal of synaptic defects in the amygdala in a mouse model of fragile X syndrome","volume":"107","author":"Suvrathan","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B264","doi-asserted-by":"publisher","first-page":"9635","DOI":"10.1523\/jneurosci.0440-09.2009","article-title":"Fluoxetine (Prozac) binding to serotonin transporter is modulated by chloride and conformational changes","volume":"29","author":"Tavoulari","year":"2009","journal-title":"J. Neurosci."},{"key":"B265","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.bbr.2011.04.049","article-title":"Genetic reduction of group 1 metabotropic glutamate receptors alters select behaviors in a mouse model for fragile X syndrome","volume":"223","author":"Thomas","year":"2011","journal-title":"Behav. Brain Res."},{"key":"B266","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00213-011-2375-4","article-title":"Group I metabotropic glutamate receptor antagonists alter select behaviors in a mouse model for fragile X syndrome","volume":"219","author":"Thomas","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"B267","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/nrn1346","article-title":"MAPK cascade signalling and synaptic plasticity","volume":"5","author":"Thomas","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"B268","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1086\/320109","article-title":"MECP2 mutations in sporadic cases of Rett syndrome are almost exclusively of paternal origin","volume":"68","author":"Trappe","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"B269","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1073\/pnas.0812394106","article-title":"Partial reversal of Rett syndrome-like symptoms in MeCP2 mutant mice","volume":"106","author":"Tropea","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B270","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1126\/science.1247190","article-title":"Oxytocin-mediated GABA inhibition during delivery attenuates autism pathogenesis in rodent offspring","volume":"343","author":"Tyzio","year":"2014","journal-title":"Science"},{"key":"B271","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.neuropharm.2012.05.004","article-title":"Role of presynaptic metabotropic glutamate receptors in the induction of long-term synaptic plasticity of vesicular release","volume":"66","author":"Upreti","year":"2013","journal-title":"Neuropharmacology"},{"key":"B272","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3389\/fncel.2014.00150","article-title":"Distinctive behavioral and cellular responses to fluoxetine in the mouse model for fragile X syndrome","volume":"8","author":"Uutela","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"B273","doi-asserted-by":"publisher","first-page":"5469","DOI":"10.1073\/pnas.1112345109","article-title":"Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior","volume":"109","author":"Veenstra-VanderWeele","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B274","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s00213-011-2276-6","article-title":"Modulation of behavioral phenotypes by a muscarinic M1 antagonist in a mouse model of fragile X syndrome","volume":"217","author":"Veeraragavan","year":"2011b","journal-title":"Psychopharmacology (Berl)"},{"key":"B275","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1037\/a0025202","article-title":"The modulation of fragile X behaviors by the muscarinic M4 antagonist, tropicamide","volume":"125","author":"Veeraragavan","year":"2011a","journal-title":"Behav. Neurosci."},{"key":"B276","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbr.2011.11.018","article-title":"Genetic reduction of muscarinic M4 receptor modulates analgesic response and acoustic startle response in a mouse model of fragile X syndrome (FXS)","volume":"228","author":"Veeraragavan","year":"2012","journal-title":"Behav. Brain Res."},{"key":"B277","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1601-183x.2011.00763.x","article-title":"The effect of an mGluR5 inhibitor on procedural memory and avoidance discrimination impairments in Fmr1 KO mice","volume":"11","author":"Vinueza Veloz","year":"2012","journal-title":"Genes Brain Behav."},{"key":"B278","doi-asserted-by":"publisher","first-page":"11624","DOI":"10.1523\/jneurosci.2266-07.2007","article-title":"Multiple Gq-coupled receptors converge on a common protein synthesis-dependent long-term depression that is affected in fragile X syndrome mental retardation","volume":"27","author":"Volk","year":"2007","journal-title":"J. Neurosci."},{"key":"B279","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/s0079-6123(03)45003-6","article-title":"Muscarinic acetylcholine receptor subtypes in cerebral cortex and hippocampus","volume":"145","author":"Volpicelli","year":"2004","journal-title":"Prog. Brain Res."},{"key":"B280","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3389\/fnbeh.2014.00104","article-title":"Lipid rafts: a signaling platform linking cholesterol metabolism to synaptic deficits in autism spectrum disorders","volume":"8","author":"Wang","year":"2014","journal-title":"Front. Behav. Neurosci."},{"key":"B281","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.nurt.2010.05.005","article-title":"Fragile X: leading the way for targeted treatments in autism","volume":"7","author":"Wang","year":"2010b","journal-title":"Neurotherapeutics"},{"key":"B282","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.gde.2012.02.002","article-title":"New perspectives on the biology of fragile X syndrome","volume":"22","author":"Wang","year":"2012a","journal-title":"Curr. Opin. Genet. Dev."},{"key":"B283","doi-asserted-by":"publisher","first-page":"346053","DOI":"10.1155\/2012\/346053","article-title":"Induced pluripotent stem cells to model and treat neurogenetic disorders","volume":"2012","author":"Wang","year":"2012","journal-title":"Neural Plast."},{"key":"B284","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3389\/fncel.2013.00028","article-title":"Reversing autism by targeting downstream mTOR signaling","volume":"7","author":"Wang","year":"2013","journal-title":"Front. Cell. Neurosci."},{"key":"B285","doi-asserted-by":"publisher","first-page":"21888","DOI":"10.1074\/jbc.M110.116293","article-title":"Roles of fragile X mental retardation protein in dopaminergic stimulation-induced synapse-associated protein synthesis and subsequent alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-4-propionate (AMPA) receptor internalization","volume":"285","author":"Wang","year":"2010a","journal-title":"J. Biol. Chem."},{"key":"B286","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/hmg\/ddh009","article-title":"Developmentally-programmed FMRP expression in oligodendrocytes: a potential role of FMRP in regulating translation in oligodendroglia progenitors","volume":"13","author":"Wang","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"B287","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.neuron.2014.11.016","article-title":"Fmr1 KO and fenobam treatment differentially impact distinct synapse populations of mouse neocortex","volume":"84","author":"Wang","year":"2014","journal-title":"Neuron"},{"key":"B288","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/j.1471-4159.2012.07722.x","article-title":"Activation of the extracellular signal-regulated kinase pathway contributes to the behavioral deficit of fragile x-syndrome","volume":"121","author":"Wang","year":"2012b","journal-title":"J. Neurochem."},{"key":"B289","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.neuron.2008.06.027","article-title":"FMRP acts as a key messenger for dopamine modulation in the forebrain","volume":"59","author":"Wang","year":"2008b","journal-title":"Neuron"},{"key":"B290","doi-asserted-by":"publisher","first-page":"4385","DOI":"10.1523\/JNEUROSCI.0646-08.2008","article-title":"Roles of calcium-stimulated adenylyl cyclase and calmodulin-dependent protein kinase IV in the regulation of FMRP by group I metabotropic glutamate receptors","volume":"28","author":"Wang","year":"2008a","journal-title":"J. Neurosci."},{"key":"B291","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3389\/fphar.2012.00189","article-title":"Group I metabotropic glutamate receptor-mediated gene transcription and implications for synaptic plasticity and diseases","volume":"3","author":"Wang","year":"2012","journal-title":"Front. Pharmacol."},{"key":"B292","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1001\/jamapsychiatry.2013.3181","article-title":"Mitigation of sociocommunicational deficits of autism through oxytocin-induced recovery of medial prefrontal activity: a randomized trial","volume":"71","author":"Watanabe","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"B293","doi-asserted-by":"publisher","first-page":"e36981","DOI":"10.1371\/journal.pone.0036981","article-title":"The therapeutic effect of memantine through the stimulation of synapse formation and dendritic spine maturation in autism and fragile X syndrome","volume":"7","author":"Wei","year":"2012","journal-title":"PLoS One"},{"key":"B294","doi-asserted-by":"publisher","first-page":"7168","DOI":"10.1073\/pnas.90.15.7168","article-title":"Metabotropic glutamate receptors trigger postsynaptic protein synthesis","volume":"90","author":"Weiler","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B295","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/455607a","article-title":"Neuroscience: fragile dopamine","volume":"455","author":"Weinshenker","year":"2008","journal-title":"Nature"},{"key":"B296","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1002\/ajmg.b.30765","article-title":"Early-phase ERK activation as a biomarker for metabolic status in fragile X syndrome","volume":"147B","author":"Weng","year":"2008","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"B297","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1517\/14740338.3.5.495","article-title":"Safety and side effect profile of fluoxetine","volume":"3","author":"Wernicke","year":"2004","journal-title":"Expert Opin. Drug Saf."},{"key":"B298","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/mp.2012.122","article-title":"What\u00e2\u20ac\u2122s hAPPening at synapses? The role of amyloid beta-protein precursor and \u00ce\u00b2-amyloid in neurological disorders","volume":"18","author":"Westmark","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"B299","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3389\/fncel.2013.00077","article-title":"Developing BACE-1 inhibitors for FXS","volume":"7","author":"Westmark","year":"2013","journal-title":"Front. Cell. Neurosci."},{"key":"B300","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1371\/journal.pbio.0050052","article-title":"FMRP mediates mGluR5-dependent translation of amyloid precursor protein","volume":"5","author":"Westmark","year":"2007","journal-title":"PLoS Biol."},{"key":"B301","first-page":"56","article-title":"MPEP reduces seizure severity in Fmr-1 KO mice over expressing human Abeta","volume":"3","author":"Westmark","year":"2010","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"B302","doi-asserted-by":"publisher","first-page":"e26549","DOI":"10.1371\/journal.pone.0026549","article-title":"Reversal of fragile X phenotypes by manipulation of A\u00ce\u00b2PP\/A\u00ce\u00b2 levels in Fmr1KO mice","volume":"6","author":"Westmark","year":"2011","journal-title":"PLoS One"},{"key":"B303","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.ceca.2010.11.009","article-title":"Activity-dependent calcium signaling and ERK-MAP kinases in neurons: a link to structural plasticity of the nucleus and gene transcription regulation","volume":"49","author":"Wiegert","year":"2011","journal-title":"Cell Calcium"},{"key":"B304","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.neuropharm.2012.11.028","article-title":"Fragile X syndrome: from targets to treatments","volume":"68","author":"Wijetunge","year":"2013","journal-title":"Neuropharmacology"},{"key":"B305","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/nrd1821","article-title":"Case history: the discovery of fluoxetine hydrochloride (Prozac)","volume":"4","author":"Wong","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"B306","doi-asserted-by":"publisher","first-page":"579382","DOI":"10.1155\/2009\/579382","article-title":"Contributions of matrix metalloproteinases to neural plasticity, habituation, associative learning and drug addiction","volume":"2009","author":"Wright","year":"2009","journal-title":"Neural Plast."},{"key":"B307","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.neuropharm.2005.06.004","article-title":"Suppression of two major fragile X syndrome mouse model phenotypes by the mGluR5 antagonist MPEP","volume":"49","author":"Yan","year":"2005","journal-title":"Neuropharmacology"},{"key":"B308","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/jnr.22546","article-title":"Fragile X mice: reduced long-term potentiation and N-Methyl-D-Aspartate receptor-mediated neurotransmission in dentate gyrus","volume":"89","author":"Yun","year":"2011","journal-title":"J. Neurosci. Res."},{"key":"B309","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.bcp.2009.09.023","article-title":"Lithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of fragile X syndrome","volume":"79","author":"Yuskaitis","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"B310","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.resp.2007.08.009","article-title":"Oral treatment with desipramine improves breathing and life span in Rett syndrome mouse model","volume":"160","author":"Zanella","year":"2008","journal-title":"Respir. Physiol. Neurobiol."},{"key":"B311","doi-asserted-by":"publisher","first-page":"5724","DOI":"10.1523\/JNEUROSCI.0795-10.2010","article-title":"Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome","volume":"30","author":"Zhang","year":"2010","journal-title":"J. Neurosci."},{"key":"B312","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1038\/nn.3864","article-title":"Dendritic channelopathies contribute to neocortical and sensory hyperexcitability in Fmr1(-\/y) mice","volume":"17","author":"Zhang","year":"2014b","journal-title":"Nat. Neurosci."},{"key":"B313","doi-asserted-by":"publisher","first-page":"15318","DOI":"10.1523\/JNEUROSCI.2162-12.2012","article-title":"Regulation of neuronal excitability by interaction of fragile X mental retardation protein with slack potassium channels","volume":"32","author":"Zhang","year":"2012","journal-title":"J. Neurosci."},{"key":"B314","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.1523\/JNEUROSCI.4900-12.2014","article-title":"Loss of MeCP2 from forebrain excitatory neurons leads to cortical hyperexcitation and seizures","volume":"34","author":"Zhang","year":"2014a","journal-title":"J. Neurosci."},{"key":"B315","doi-asserted-by":"publisher","first-page":"10561","DOI":"10.1523\/JNEUROSCI.2666-08.2008","article-title":"The tyrosine phosphatase STEP mediates AMPA receptor endocytosis after metabotropic glutamate receptor stimulation","volume":"28","author":"Zhang","year":"2008","journal-title":"J. Neurosci."},{"key":"B316","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.1523\/jneurosci.3553-04.2005","article-title":"A GIT1\/PIX\/Rac\/PAK signaling module regulates spine morphogenesis and synapse formation through MLC","volume":"25","author":"Zhang","year":"2005","journal-title":"J. Neurosci."},{"key":"B317","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1152\/jn.00601.2009","article-title":"MeCP2 is required for normal development of GABAergic circuits in the thalamus","volume":"103","author":"Zhang","year":"2010","journal-title":"J. Neurophysiol."},{"key":"B318","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/j.1471-4159.2004.02350.x","article-title":"Comparative signaling pathways of insulin-like growth factor-1 and brain-derived neurotrophic factor in hippocampal neurons and the role of the PI3 kinase pathway in cell survival","volume":"89","author":"Zheng","year":"2004","journal-title":"J. Neurochem."},{"key":"B319","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1093\/brain\/awf252","article-title":"Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy. Brain-derived neurotrophic factor","volume":"125","author":"Ziemssen","year":"2002","journal-title":"Brain"},{"key":"B320","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/sj.clpt.6100012","article-title":"Aminoglycoside-induced translational read-through in disease: overcoming nonsense mutations by pharmacogenetic therapy","volume":"81","author":"Zingman","year":"2007","journal-title":"Clin. Pharmacol. Ther."},{"key":"B321","doi-asserted-by":"publisher","first-page":"a009886","DOI":"10.1101\/cshperspect.a009886","article-title":"Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities","volume":"4","author":"Zoghbi","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B322","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1124\/jpet.108.143990","article-title":"Inactivation of the maternal fragile X gene results in sensitization of GABAB receptor function in the offspring","volume":"327","author":"Zupan","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Frontiers in Cellular Neuroscience"],"original-title":[],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T08:59:58Z","timestamp":1566377998000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fncel.2015.00055\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,26]]},"references-count":322,"URL":"https:\/\/doi.org\/10.3389\/fncel.2015.00055","relation":{},"ISSN":["1662-5102"],"issn-type":[{"value":"1662-5102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,26]]}}}